Estimation of the parameters of the renin-angiotensin-aldosterone system, water-electrolyte metabolism, and endothelial function in newborns of women with chronic hypertension

Human Physiology - Tập 41 - Trang 104-108 - 2015
G. N. Chistyakova1, I. A. Gazieva1, I. I. Remizova1
1Department of Immunology and Clinical Microbiology, Ural Research Institute of Maternity and Infancy, Ministry of Health of Russia, Yekaterinburg, Russia

Tóm tắt

The parameters of the renin-angiotensin-aldosterone system (RAAS), natriuretic peptides, and markers of endothelial function in the early neonatal period and at an age of three months were estimated in 83 full-term infants of women with chronic hypertension, including 60 newborns of women with chronic hypertension of mild to moderate severity (the main group) and 23 newborns of women without hypertension (the comparison group). The levels of renin, angiotensin-II, aldosterone, natriuretic peptides, and endothelin-1 in the umbilical cord and peripheral blood were determined by enzyme-linked immunosorbent assay (ELISA); those of stable metabolites of nitrogen, by the Griess method. Newborn of women with chronic hypertension exhibited a significant elevation of the renin, angiotensin II, and brain natriuretic peptide levels at birth. A statistically significant increase in the concentration of atrial natriuretic peptide (ANP1–28) was detected in these infants on the third to fifth day of life. In addition, the infants of this group have significantly higher levels of renin, angiotensin II, and endothelin-1 and decreased levels of endogenous nitrite at the age of three months. The results of our study indicate prenatal activation of the RAAS in the fetus. The elevated RAAS activity persisted in infants of women with chronic hypertension during the first three months of life and endothelial dysfunction in these infants developing by the age of three months.

Tài liệu tham khảo

Diagnostika i lechenie arterial’noi gipertenzii u beremennykh. Klinicheskie rekomendatsii (Diagnosis and Treatment of Hypertension in Pregnancy: Clinical Recommendations), Moscow: Vserossiiskoe Nauchnoe Obshchestvo Kardiologov, Rossiiskoe Meditsinskoe Obshchestvo po Arterial’noi Gipertonii, 2010, p. 84. Roberts, C.L., Algert, C.S., Morris, J.M., et al., Hypertensive disorders in pregnancy: a population-based study, Med. J. Australia, 2005, vol. 182, no. 7, p. 332. Jesuino, F.A., Casqueiro, J.B., and Moreira, L.M.O., Study on the prevalence of arterial hypertension in mothers of low birth weight newborns, Einstein, 2006, vol. 4, no. 4, p. 298. Smirnov, I.E., Shakina, L.D., Rivne, Y., et al. Endothelial dysfunction in hypoxic-ischemic brain damage in infants, Russ. J. Pediatr., 2010, vol. 4, p. 32. Beer, M., Vrijkotte, T.G.M., Wal, M.F., et al., Relation of maternal hypertension with infant growth in a prospective birth cohort: the ABCD study, J. Dev. Orig. Health Dis., 2010, vol. 1, no. 5, p. 347. Nosikov, V.V., Tereshchenko, S.N., Zateyschikov, D.A., et al., Gene polymorphism of angiotensin converting enzyme, angiotensin II, NO-synthase, and estrogen receptor and gender differences in their influence on the development of cardiovascular disease, Kardiologiya, 2009, vol. 4, p. 58. Khamidullaeva, G., Kevorkov, A., and Eliseyeva, M., Genetic aspect of endothelium dysfunction in Uzbek hypertensive patients, MHSJ, 2010, vol. 4, p. 30. Balam-Ortiz, E., Esquivel-Villarreal, A., Huerta-Hernandez, D., et al., Hypercontrols in genotype-phenotype analysis reveal ancestral haplotypes associated with essential hypertension, Hypertension, 2012, vol. 59, p. 847. Chatsuriyawong, S., Gozal, D., Kheirandish-Gozal L., et al. Genetic variance in nitric oxide synthase and endothelin genes among children with and without endothelial dysfunction, J. Transl. Med., 2013, vol. 11, p. 227. Shishkin, A.N. and Lyndin, M.L, Endothelial dysfunction and hypertension, Arter. Gipert., 2008, vol. 14, no. 4, p. 315. Versari, D., Daghini, E., Virdis, A., et al., Endothelium-dependent contractions and endothelial dysfunction in human hypertension. Br. J. Pharmacol., 2009, vol. 157, no. 4, p. 527. Gafarova, F.M., The state of carbohydrate metabolism and its relationship with the level of nitric oxide (NO) in the blood of newborns with increased perinatal risk, Pediatriya, 2009, vol. 87, no. 4, p. 158. Kaur, C., Sivakumar, V., Ang, L.S., and Sundaresan, A., Hypoxic damage to the periventricular white matter in neonatal brain: role of vascular endothelial growth factor, nitric oxide and excitotoxicity, J. Neurochem., 2006, vol. 98, no. 4, p. 1200. Popova, I.G., Laboratory evaluation of endothelial function in term infants born to mothers with preeclampsia, Klin. Lab. Diagn., 2009, vol. 6, p. 12. Afonin, A.A., Strogulin, V.V., Loginov, I.G., et al., Dynamics of cerebral hemodynamics and endothelium factors of its regulation in children with perinatal CNS disease in the first year of life, Pediatriya, 2011, vol. 90, no. 1, p. 30. Armstead, W.M. and Raghupathi, R., Endothelin and the neurovascular unit in pediatric traumatic brain injury, Neurol. Res., 2011, vol. 33, no. 2, p. 127. Kumar, A., Mittal, R., Khanna, H.D, and Basu, S., Free radical injury and blood-brain barrier permeability in hypoxic-ischemic encephalopathy, Pediatrics, 2008, vol. 122, no. 3, p. 722. Tsyvian, P.B., Markova, T.V., Mikhailova, S.V., et al., Left ventricular isovolumic relaxation and renin-angiotensin-aldosterone system in the growth restricted fetus, Eur. J. Obst. Gyn. Reprod. Biol., 2008, vol. 140, p. 33. Martinerie, L., Pussard, E., Foix-L’hélias, L., et al., Physiological partial aldosterone resistance in human newborns, Pediatr. Res. 2009, vol. 66, no. 3, p. 323. Gluckman, P.D. and Hanson, M.A., Developmental origins of disease paradigm: a mechanistic and evolutionary perspective, Pediatr. Res. 2004, vol. 56, no. 3, p. 311. Mannarino, S., Garofoli, F., Mongini, E. BNP concentrations and cardiovascular adaptation in preterm and fullterm newborn infants, Early Hum. Dev., 2010, vol. 86, no. 5, p. 295.